Calendar

Latest Media

Utrophin R&D Day

15 June 2016, 13:30 BST / 8:30am EDT

Click to view


Ridinilazole: Preserving the microbiome to reduce CDI

Ridinilazole: Preserving the microbiome to reduce CDI

Stocks

Share Price

LSE: SUMM
110.00p 4.50
at 04:57pm GMT 28 Jun 2016

NASDAQ: SMMT
$7.91 0.20
at 12:08pm ET 28 Jun 2016

Current Programmes

  • C. Difficile Infections banner image

    C. difficile Infection

    Clostridium difficile infection (‘CDI’) is a major healthcare issue in hospitals, long-term care homes, and increasingly in the wider community. It is a serious illness caused by infection of the colon by the bacteria, C. difficile, which produces toxins that cause inflammation, severe diarrhoea and can in the most serious of cases be fatal.

    Read More
  • Duchenne Muscular Dystrophy image boy

    Duchenne Muscular Dystrophy

    Duchenne Muscular Dystrophy (‘DMD’) is a fatal, genetic disease that predominantly affects boys. It has a population of around 50,000 in the developed world and is classified as a rare or orphan disease. DMD is caused by the absence of a protein called dystrophin which is essential in maintaining the healthy function of muscles in the body.

    Currently there is no disease modifying treatment for all patients with DMD.

    Read More